ArticleAlzheimer's research & therapy2015

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.

Haakon B Nygaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.